Since June 2022, SEQALIS is the new trademark of BIO.be SA. The company offers analytical and customized R&D services in anatomo-pathology, cytogenetics and molecular biology (Next Gen Sequencing & PCR) to the biotech, pharma and more widely to the life sciences sector. We focus on immuno-oncology (immuno-monitoring) and in quality control for cell and gene therapies. To know more
